Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous stem cell therapy for severe knee osteoarthritis
IRCT20180102038184N1Phase 2Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Oct 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous stem cell therapy in knee osteoarthritis (OA), sponsored by Urmia University of Medical Sciences. Primary endpoint: Clinical signs and symptoms of osteoarthritis. Started Oct 2018; status: completed.
02
Drugs
autologous stem cell therapy
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20180102038184N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180102038184N1.